Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Melatonin as a novel cardioprotective therapy in pulmonary hypertension

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Maarman, Gerald Jerome
Other Authors: Lecour, Sandrine
Format: Thesis
Language:English
Published: Department of Medicine 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613251301277696
access_status_str Open Access
author Maarman, Gerald Jerome
author2 Lecour, Sandrine
author_browse Lecour, Sandrine
Maarman, Gerald Jerome
author_facet Lecour, Sandrine
Maarman, Gerald Jerome
author_sort Maarman, Gerald Jerome
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/12872
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:33:10.259Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Department of Medicine
publisherStr Department of Medicine
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/12872 Melatonin as a novel cardioprotective therapy in pulmonary hypertension Maarman, Gerald Jerome Lecour, Sandrine Sliwa-Hahnle, Karen Medicine Includes bibliographical references. Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure which leads to right ventricular hypertrophy and failure. The mechanism involved in the pathophysiology of the disease remains unclear but it is suggested that oxidative stress may trigger cardiovascular dysfunction associated with the disease. To date, there is no efficient therapy against PH and novel therapies are urgently needed. Melatonin is a powerful antioxidant that can confer benefit against ischemia-reperfusion injury and hypertension. We therefore hypothesised that melatonin may confer cardiovascular benefits against PH. Methods: Oxidative stress (plasma lipid peroxidation, antioxidant capacity and antioxidant enzyme activity) was assessed in healthy (n=10), in patients with PH (n=10), in Long Evans rats (n≥6) or in a rat model of PH induced 28 days after the injection of monocrotaline (MCT, 80mg/kg, subcutaneous) (n≥6). Melatonin (75ng/L, nutritional concentration), 4mg/kg or 6mg/kg (therapeutic dose) was given daily in the drinking water of rats, with the treatment started 5 days before the injection of MCT, on the day of the injection or 14 days after the injection of MCT. The development of PH was measured by assessing right ventricular hypertrophy, cardiac fibrosis, oxidative stress and cardiac function (via echocardiography and the isolated heart Langendorff perfusion model). Results: Plasma oxidative stress was increased in both patients and rats with PH compared with their respective controls. A chronic treatment with melatonin (75ng/L, 4mg/kg or 6mg/kg) starting on the day of the injection with MCT in rats with PH reduced right ventricular hypertrophy, cardiac dysfunction and plasma oxidative stress compared with control rats. Furthermore, the beneficial effect of melatonin (6mg/kg) could be observed when given as a preventive (5 days prior to the injection of MCT) or as a curative therapy (14 days after the injection of MCT). Conclusions: Our data demonstrate that chronic treatment of melatonin confers cardioprotection in a rat model of PH. As melatonin is inexpensive, safe (no reported side effects) and already available over the counter in many countries, we propose that melatonin should be considered as a novel preventive/curative therapy to limit cardiac dysfunction in patients with PH. 2015-05-26T14:15:48Z 2015-05-26T14:15:48Z 2014 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/12872 eng application/pdf Department of Medicine Faculty of Health Sciences University of Cape Town
spellingShingle Medicine
Maarman, Gerald Jerome
Melatonin as a novel cardioprotective therapy in pulmonary hypertension
thesis_degree_str Doctoral
title Melatonin as a novel cardioprotective therapy in pulmonary hypertension
title_full Melatonin as a novel cardioprotective therapy in pulmonary hypertension
title_fullStr Melatonin as a novel cardioprotective therapy in pulmonary hypertension
title_full_unstemmed Melatonin as a novel cardioprotective therapy in pulmonary hypertension
title_short Melatonin as a novel cardioprotective therapy in pulmonary hypertension
title_sort melatonin as a novel cardioprotective therapy in pulmonary hypertension
topic Medicine
url http://hdl.handle.net/11427/12872
work_keys_str_mv AT maarmangeraldjerome melatoninasanovelcardioprotectivetherapyinpulmonaryhypertension